Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2004 February;56(1) > Minerva Pediatrica 2004 February;56(1):63-72

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS   

Minerva Pediatrica 2004 February;56(1):63-72

Copyright © 2004 EDIZIONI MINERVA MEDICA

language: English

The role of radiofrequency ablation for pediatric supraventricular tachycardia

Campbell R. M., Strieper M. J., Frias P. A.


PDF


Radiofrequency ablation has become frontline therapy for many pediatric patients with common supraventricular tachycardia (SVTs). Rather than long-term treatment with medications, radiofrequency ablation offers the possibility of ''cure'' for certain SVT substrates. The decision to perform radiofrequency ablation should be made after full disclosure with the patient and parents about radiofrequency ablation (RFA) benefits and risk, alternative therapies, and the natural history of the SVT. This paper presents a discussion about the current status of RFA and common pediatric SVTs, as well as, discussing evolving RFA issues and indications.

top of page